High Prevalence of Diabetes Mellitus and Advancements in Technology to Augment Market

Within the blood glucose monitoring systems market, at present, companies are increasingly focusing on the development of advanced next-generation glucose monitoring systems to gain an edge in the current market landscape. Non-invasive glucose monitoring techniques have gained noteworthy popularity over the past couple of decades, and the trend is set to continue to gain momentum during the forecast period. Technological advancements continue to drive innovations in the blood glucose monitoring systems market and improve diagnostic techniques and equipment. Research and development activities continue to explore and discover new non-invasive glucose monitoring techniques.

Over the past few years, research and development activities have put forward infrared spectroscopy– a novel technology that is expected to offer tremendous scope in the blood glucose monitoring systems market. Rapid advancements in technology and improvement in the reliability and calibrating methods of non-invasive devices are some of the factors that are expected to augment the growth of the market for blood glucose monitoring systems in the coming years. The high prevalence of diabetes worldwide is one of the major causes of morbidity and mortality in most regions around the world. Surge in the aging population worldwide, unhealthy dietary patterns, an increase in the number of individuals leading a sedentary lifestyle and obesity are expected to increase the prevalence of diabetes mellitus in the coming years which in turn is expected to propel the demand for advanced blood glucose monitoring systems. At the back of these factors coupled with favorable government policies, the global blood glucose monitoring systems market is expected to reach ~US$ 25 Bn by the end of 2027.

blood glucose monitoring systems market infographic

To know the scope of our report Get a Sample on Blood Glucose Monitoring Systems Market

High Adoption of Non-invasive Monitoring Leveraging Optical Techniques Likely to Propel Market Growth

Due to the growing prevalence of diabetes mellitus across the world, the pursuit of efficient blood glucose monitoring systems has gained considerable pace over the past few years– a trend that is likely to continue during the forecast period. Governments of both the developing as well as developed nations of the world are increasingly encouraging research and development activities that aim to minimize health complications caused by blood glucose levels. Non-invasive blood glucose monitoring systems have gained considerable traction in recent years of which, vibrational spectroscopy-based techniques of the skin have emerged as promising candidates.

Get a glimpse of the in-depth analysis through our Report Brochure

At present, researchers are also increasingly investigating the potential benefits of deploying devices based on photoplethysmography, wherein wavelengths in near-infrared range are being considered for their exceptional capabilities of offering dependable blood glucose monitoring predictions. Optical glucose sensing is projected to remain one of the most critical types of treatment within the blood glucose monitoring systems market during the forecast period. Steady progress in biosensor technologies and growing emphasis on non-invasive blood glucose monitoring is expected to further accelerate the adoption of optical techniques in the blood glucose monitoring systems market. Advancements in technology have paved the way for a host of blood glucose monitoring systems and techniques, including Raman spectroscopy, fluorescence spectroscopy, absorption spectroscopy, photoacoustic spectroscopy, and ocular spectroscopy, among others.

The future of the blood glucose monitoring systems market is expected to hinge on the strides taken by nanotechnology and significant progress in biomaterials. Companies operating in the current market landscape are expected to develop glucose biosensors that are predominantly based on polymer nanocomposites, carbon nanotubes, and grapheme.

Market Participants Develop Smart Blood Glucose Monitoring Systems to Gain Advantage

With technology progressing at a rapid pace, several companies are inclined toward the development of advanced blood glucose monitoring systems based on these technologies. Participants in the blood glucose monitoring systems market are expected to collaborate with pharmaceutical companies to launch reliable next-generation glucose monitoring systems. For instance, in January 2019, Eris Lifesciences and India Medtronic Pvt. Ltd announced that the two companies are collaborating to formulate efficient diabetes monitoring programs and initiatives in India. Both companies will leverage expertise from one another to develop advanced blood glucose monitoring systems. Both the companies announced the launch of the smart continuous blood glucose monitoring system, which can be connected with smartphones to gain real-time data, including glucose levels without excessive hardware requirements. Moreover, established brands are also launching new products and expanding their product range to improve their market share. For instance, in January 2018, Abbott announced the launch of the FreeSbtyle Libre System, an advanced continuous glucose monitoring system.

blood glucose monitoring systems market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global blood glucose monitoring systems market is expected to grow at a steady CAGR of ~5.5% during the forecast period. Some of the leading factors that will contribute to market growth include rapid developments in optical and non-invasive monitoring techniques, high prevalence of diabetes mellitus worldwide, rise in the geriatric population, and policies by government bodies worldwide that encourage the development of reliable, accurate, and efficient blood glucose monitoring systems. Companies should focus on expanding their product portfolio, improve the accuracy of their products, and continue to invest in new technologies to improve their market share in the current market landscape.

Blood Glucose Monitoring Systems Market: Overview

  • According to Transparency Market Research’s latest research report on the global blood glucose monitoring systems market for the historical period (2017–2018) and the forecast period (2019–2027), rise in prevalence of diabetes is anticipated to drive the global blood glucose monitoring systems market in the near future
  • According to the report, the global blood glucose monitoring systems market was valued at US$ 15.4 Bn in 2018 and is projected to expand at a CAGR of 5.5% from 2019 to 2027

Rise in Prevalence of Diabetes: A Key Driver for Blood Glucose Monitoring Systems Market

  • Complex interaction between genes and environmental factors are responsible for causing type 1 diabetes. Obesity, dietary habits, family history of diabetes, and physical inactivity are the major risk factors for type 2 diabetes.
  • Prevalence of diabetes is rising due to change in lifestyle, environmental factors, and genetic mutation. Moreover, obesity is a key risk factor responsible for causing diabetes.
  • According to the American Diabetes Association, an estimated 30.3 million people in the U.S. had diabetes in 2015, among these 1.25 million were children
  • According to the World Health Organization, an estimated 1.6 million deaths occurred due to diabetes in 2016
  • A report published by the World Health Organization stated that an estimated 422 million adults were living with diabetes globally in 2014 and the prevalence is rising in the adult population
  • According to the British Diabetic Association operating as Diabetes UK, in the U.K., 3.8 million people were diagnosed with diabetes in 2019
  • According to Diabetes U.K., 382 million adults across the globe aged between 20 and 79 had diabetes in 2012. This number is expected to reach 592 million by 2035. An estimated 175 million people are undiagnosed with type 2 diabetes.
  • Prevalence of diabetes is variable and is expected to increase in the near future

Increase in Awareness about Diabetes: Blood Glucose Monitoring Systems Market

  • Diabetes is a leading cause of death across the world. Prevalence of diabetes is increasing in the adult as well as pediatric population.
  • In November 2018, the American Diabetes Association entered into a partnership with American Heart Association to increase awareness about cardiovascular diseases caused due to type 2 diabetes
  • Diabetes is a leading cause of deaths in India. The Ministry of Health and Family Welfare (MoHFW) launched mDiabetes, a mobile health initiative for prevention and care of diabetes, in collaboration with the WHO Country Office for India and other partners.
  • The Division of Diabetes and Translation, a department of CDC, supports activities and programs to prevent type 2 diabetes and improve patient health outcomes
  • In March 2015, the NHS and Public Health England launched a National NHS Diabetes Prevention Program. Prevalence of type 2 diabetes reduced in the U.K. due to this program.
  • The National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases and Stroke is arranged by National Health Mission. The aim of the program is to strengthen the infrastructure, early diagnostics by primary healthcare system, and health prevention from diabetes.
  • In November 2018, Onduo conducted a virtual diabetes program for people living with type 2 diabetes in Georgia

 High Cost of Blood Glucose Monitoring Systems to Hamper Global Market

  • Cost is a major factor influencing the selection of treatment. The cost of traditional methods for diabetes management is less than that for digital diabetes management.
  • The cost of digital diabetes management devices is a barrier in the treatment of type 1 diabetes in adults
  • According to an article published in AJMC, the estimated cost of insulin infusion pump per person is about US$ 4,500, with additional cost for supplies exceeding US$ 1,500 per year
  • Hence, the high cost of the blood glucose monitoring systems can restrain the market

Patient and Provider Burden to Restrain Global Blood Glucose Monitoring Systems Market

  • Diabetes is among the leading causes of death across the globe. According to the World Health Organization, prevalence of diabetes is increasing in low and middle income countries. The prevalence of diabetes increased from 4.7 % in 1980 to 8.5% in 2014.
  • According to the Centers for Diseases Control and Prevention, an estimated 30.3 million people in the U.S. had diabetes in 2017
  • According to the National Institute of Diabetes and Digestive and Kidney Diseases, in the U.S., 23.1 million patients were diagnosed with diabetes at a cost of more than US$ 245 Mn per year
  • Lack of providers affects people with diabetes in rural areas
  • Rise in prevalence of diabetes is increasing the demand and supply gap for healthcare providers

Blood Glucose Monitoring Systems Market: Competition Landscape

  • This report profiles major players operating in the global blood glucose monitoring systems market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global blood glucose monitoring systems market is moderately fragmented, with the presence of a few large players in the international market and numerous small players in regional markets. The top four to five players hold major share of the global blood glucose monitoring systems market.
  • Prominent players operating in the global blood glucose monitoring systems market  include
    • Abbott
    • Medtronic
    • Hoffmann-La Roche Ltd
    • B.Braun Melsungen AG
    • AgaMatrix
    • Sanofi-aventis
    • SD Biosensor, INC
    • LifeScan
    • Ascensia Diabetes Care
    • Prodigy Diabetes Care, LLC
    • Nipro
    • Dexcom, Inc.
    • Ypsomed AG
    • Senseonics
    • ACON Laboratories, Inc.
  • The report on the global blood glucose monitoring systems market discusses individual strategies, followed by company profiles of manufacturers of blood glucose monitoring systems. The ‘competitive landscape’ section has been included in the blood glucose monitoring systems market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global blood glucose monitoring systems market.

Blood Glucose Monitoring Systems Market – Segmentation

Product

Self-monitoring Blood Glucose Systems

  • Blood Glucose Meters
  • Testing Strips
  • Lancing Devices
  • Lancets

Continuous Glucose Monitoring Systems

  • Sensors
  • Transmitters
  • Receivers

Application

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Testing Site

Fingertip Testing

Alternate Site Testing

Patient Care Setting

Self/Home Care

Hospitals

Clinics

Region

Americas

Europe

Asia Pacific

Middle East & Africa

Frequently Asked Questions

The global blood glucose monitoring systems market was worth US$ 15.4 Bn and is projected to reach a value of US$ 25 Bn by the end of 2027

Blood glucose monitoring systems market is anticipated to grow at a CAGR of 5.5% during the forecast period

Americas accounted for a major share of the global blood glucose monitoring systems market

Blood Glucose Monitoring Systems Market is driven by rise in prevalence of diabetes, rapid advancements in technology and improvement in the reliability and calibrating methods of non-invasive devices

Key players in the global blood glucose monitoring systems market include Abbott, Medtronic, Hoffmann-La Roche Ltd., B. Braun Melsungen AG, AgaMatrix, Sanofi, SD Biosensor, Inc., LifeScan, Ascensia Diabetes Care, Prodigy Diabetes Care, LLC, Nipro, Dexcom, Inc., Ypsomed AG, Senseonics, and ACON Laboratories, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Glucose Monitoring Systems Market 

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Price Analysis

        5.1.1. Average Price per Meter and Strip

        5.1.2. Reimbursement Price by Region 

    5.2. Disease Prevalence & Incidence Rate Globally with Key Countries

    5.3. Key Vendor and Distributor Analysis

    5.4. Reimbursement Scenario by Region/Globally

    5.5. Supply Chain Analysis, by Country (Market Structure)

    5.6. Marketing Strategies and Promotional Activities

6. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2027

        6.3.1. Self-monitoring Blood Glucose Systems

            6.3.1.1. Blood Glucose Meters

            6.3.1.2. Testing Strips

            6.3.1.3. Lancing Devices

            6.3.1.4. Lancets

        6.3.2. Continuous Glucose Monitoring Systems

            6.3.2.1. Sensors

            6.3.2.2. Transmitters

            6.3.2.3. Receivers

    6.4. Market Attractiveness, by Product Type

7. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2027

        7.3.1. Type 1 Diabetes

        7.3.2. Type 2 Diabetes

        7.3.3. Gestational Diabetes

    7.4. Market Attractiveness, by Application

8. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Testing Site

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Testing Site, 2017–2027

        8.3.1. Fingertip Testing

        8.3.2. Alternate Site Testing

    8.4. Market Attractiveness, by Testing Site

9. Global Blood Glucose Monitoring Systems Market  Analysis and Forecast, by Patient Care Settings

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by Patient Care Settings, 2017–2027

        9.3.1. Self/Home Care

        9.3.2. Hospitals

        9.3.3. Clinics

    9.4. Market Attractiveness, by Patient Care Settings 

10. Global Blood Glucose Monitoring System Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. Americas 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Middle East & Africa 

    10.3. Market Attractiveness, by Country/Region

11. Americas Blood Glucose Monitoring System Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2027

        11.2.1. Self-monitoring Blood Glucose Systems

            11.2.1.1. . Blood Glucose Meters

            11.2.1.2. Testing Strips

            11.2.1.3.  Lancing Devices

            11.2.1.4. Lancets

        11.2.2. Continuous Glucose Monitoring Systems

            11.2.2.1. Sensors

            11.2.2.2. Transmitters

            11.2.2.3. Receivers

    11.3. Market Value Forecast, by Application, 2017–2027

        11.3.1. Type 1 Diabetes

        11.3.2. Type 2 Diabetes

        11.3.3. Gestational Diabetes

    11.4. Market Value Forecast, by Testing Site, 2017–2027

        11.4.1. Fingertip Testing

        11.4.2. Alternate Site Testing

    11.5. Market Value Forecast, by Patient Care Settings, 2017–2027

        11.5.1. Self/Home Care

        11.5.2. Hospitals

        11.5.3. Clinics

    11.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        11.6.1.  U.S.

        11.6.2. Canada

        11.6.3.  Brazil

        11.6.4.  Mexico

        11.6.5.  Rest of Americas

    11.7. Market Attractiveness Analysis 

        11.7.1.  By Product Type 

        11.7.2.  By Application 

        11.7.3.  By Testing Site 

        11.7.4.  By Patient Care Settings 

        11.7.5.  By Country/Sub-region

    11.8. Market Share Analysis by Region for Big and Mid-sized Players

12. Europe Blood Glucose Monitoring System Market Analysis and Forecast

    12.1. Introduction

        12.1.1.  Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2027

        12.2.1. Self-monitoring Blood Glucose Systems

            12.2.1.1.  Blood Glucose Meters

            12.2.1.2.  Testing Strips

            12.2.1.3.  Lancing Devices

            12.2.1.4.  Lancets

        12.2.2.  Continuous Glucose Monitoring Systems

            12.2.2.1.  Sensors

            12.2.2.2.  Transmitters

            12.2.2.3.  Receivers

    12.3. Market Value Forecast, by Application, 2017–2027

        12.3.1.  Type 1 Diabetes

        12.3.2.  Type 2 Diabetes

        12.3.3.  Gestational Diabetes

    12.4. Market Value Forecast, by Testing Site, 2017–2027

        12.4.1.  Fingertip Testing

        12.4.2.  Alternate Site Testing

    12.5. Market Value Forecast, by Patient Care Settings, 2017–2027

        12.5.1.  Self/Home Care

        12.5.2.  Hospitals

        12.5.3.  Clinics

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.6.1.  Germany

        12.6.2.  U.K.

        12.6.3.  France

        12.6.4.  Spain

        12.6.5.  Italy

        12.6.6.  Poland

        12.6.7.  Romania

        12.6.8.  Portugal

        12.6.9.  Netherlands

        12.6.10.  Czech

        12.6.11.  Israel

        12.6.12.  Austria 

        12.6.13.  Sweden

        12.6.14.  Denmark

        12.6.15.  Switzerland

        12.6.16.  Rest of Europe

    12.7. Market Attractiveness Analysis 

        12.7.1.  By Product Type 

        12.7.2.  By Application 

        12.7.3.  By Testing Site 

        12.7.4.  By Patient Care Settings 

        12.7.5.  By Country/Sub-region

    12.8. Market Share Analysis by Region for Big and Mid-sized Players

13. Asia Pacific Blood Glucose Monitoring System Market Analysis and Forecast

    13.1. Introduction

        13.1.1.  Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2027

        13.2.1.  Self-monitoring Blood Glucose Systems

            13.2.1.1.  Blood Glucose Meters

            13.2.1.2.  Testing Strips

            13.2.1.3.  Lancing Devices

            13.2.1.4.  Lancets

        13.2.2.  Continuous Glucose Monitoring Systems

            13.2.2.1.  Sensors

            13.2.2.2. Transmitters

            13.2.2.3.  Receivers

    13.3. Market Value Forecast, by Application, 2017–2027

        13.3.1.  Type 1 Diabetes

        13.3.2.  Type 2 Diabetes

        13.3.3.  Gestational Diabetes

    13.4. Market Value Forecast, by Testing Site, 2017–2027

        13.4.1.  Fingertip Testing

        13.4.2.  Alternate Site Testing

    13.5. Market Value Forecast, by Patient Care Settings, 2017–2027

        13.5.1.  Self/Home Care

        13.5.2.  Hospitals

        13.5.3.  Clinics

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.6.1.  China

        13.6.2.  Japan

        13.6.3.  India

        13.6.4.  Indonesia

        13.6.5.  Philippines

        13.6.6.  Vietnam

        13.6.7.  Malaysia

        13.6.8.  Australia & New Zealand

        13.6.9.  Rest of Asia Pacific

    13.7. Market Attractiveness Analysis 

        13.7.1.  By Product Type 

        13.7.2.  By Application 

        13.7.3.  By Testing Site 

        13.7.4.  By Patient Care Settings 

        13.7.5.  By Country/Sub-region

    13.8. Market Share Analysis by Region for Big and Mid-sized Players

14. Middle East & Africa Blood Glucose Monitoring System Market Analysis and Forecast

    14.1. Introduction

        14.1.1.  Key Findings

    14.2. Market Value Forecast, by Product Type, 2017–2027

        14.2.1.  Self-monitoring Blood Glucose Systems

            14.2.1.1.  Blood Glucose Meters

            14.2.1.2.  Testing Strips

            14.2.1.3.  Lancing Devices

            14.2.1.4.  Lancets

        14.2.2. Continuous Glucose Monitoring Systems

            14.2.2.1.  Sensors

            14.2.2.2.  Transmitters

            14.2.2.3.  Receivers

    14.3. Market Value Forecast, by Application, 2017–2027

        14.3.1.  Type 1 Diabetes

        14.3.2.  Type 2 Diabetes

        14.3.3.  Gestational Diabetes

    14.4. Market Value Forecast, by Testing Site, 2017–2027

        14.4.1.  Fingertip Testing

        14.4.2.  Alternate Site Testing

    14.5. Market Value Forecast, by Patient Care Settings, 2017–2027

        14.5.1.  Self/Home Care

        14.5.2.  Hospitals

        14.5.3.  Clinics

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        14.6.1.  GCC Countries

        14.6.2.  South Africa

        14.6.3.  Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis 

        14.7.1.  By Product Type 

        14.7.2.  By Application 

        14.7.3.  By Testing Site 

        14.7.4. By Patient Care Settings 

        14.7.5.  By Country/Sub-region

    14.8. Market Share Analysis by Region for Big and Mid-sized Players

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis, by Company (2018)

    15.3. Company Profiles

        15.3.1.  Abbott 

            15.3.1.1. Company Overview

            15.3.1.2. Company Financials

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis

        15.3.2.  Medtronic

            15.3.2.1. Company Overview

            15.3.2.2. Company Financials

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3.  F. Hoffmann-La Roche Ltd

            15.3.3.1. Company Overview

            15.3.3.2. Company Financials

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4.  B.Braun Melsungen AG

            15.3.4.1. Company Overview

            15.3.4.2. Company Financials

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5.  AgaMatrix

            15.3.5.1. Company Overview

            15.3.5.2. Company Financials

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6.  Sanofi-aventis 

            15.3.6.1. Company Overview

            15.3.6.2. Company Financials

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7.  SD Biosensor, INC

            15.3.7.1. Company Overview

            15.3.7.2. Company Financials

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8.  LifeScan

            15.3.8.1. Company Overview

            15.3.8.2. Company Financials

            15.3.8.3. Growth Strategies

            15.3.8.4. SWOT Analysis

        15.3.9.  Ascensia Diabetes Care

            15.3.9.1. Company Overview

            15.3.9.2. Company Financials

            15.3.9.3. Growth Strategies

            15.3.9.4. SWOT Analysis

        15.3.10.  Prodigy Diabetes Care, LLC

            15.3.10.1. Company Overview

            15.3.10.2. Company Financials

            15.3.10.3. Growth Strategies

            15.3.10.4. SWOT Analysis

        15.3.11.  Nipro

            15.3.11.1. Company Overview

            15.3.11.2. Company Financials

            15.3.11.3. Growth Strategies

            15.3.11.4. SWOT Analysis

        15.3.12. Dexcom, Inc.

            15.3.12.1. Company Overview

            15.3.12.2. Company Financials

            15.3.12.3. Growth Strategies

            15.3.12.4. SWOT Analysis

        15.3.13. Ypsomed AG

            15.3.13.1. Company Overview

            15.3.13.2. Company Financials

            15.3.13.3. Growth Strategies

            15.3.13.4. SWOT Analysis

        15.3.14.  ACON Laboratories, Inc

            15.3.14.1. Company Overview

            15.3.14.2. Company Financials

            15.3.14.3. Growth Strategies

            15.3.14.4. SWOT Analysis

        15.3.15. Senseonics

            15.3.15.1. Company Overview

            15.3.15.2. Company Financials

            15.3.15.3. Growth Strategies

            15.3.15.4. SWOT Analysis

        15.3.16.  Other Prominent Players

List of Table

Table 01 Diabetes Prevalence in Key Countries 

Table 02 Diabetes Prevalence in Key Countries

Table 03 Diabetes Prevalence in Key Countries

Table 04 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 05 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027

Table 06 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Continuous Glucose Monitoring Systems, 2017–2027

Table 07 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 08 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Testing Site, 2017-2027

Table 09 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027

Table 10 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 11 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 13 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027

Table 14 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Continuous Glucose Monitoring Systems, 2017–2027

Table 15 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 16 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2017–2027

Table 17 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027

Table 18 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 19 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 21 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027

Table 22 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Continuous Glucose Monitoring Systems, 2017–2027

Table 23 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 24 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2017-2027

Table 25 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027

Table 26 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 27 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 28 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027

Table 29 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, Continuous Glucose Monitoring Systems, 2017–2027

Table 30 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2017-2027

Table 31 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2017-2027

Table 32 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027

Table 33 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 34 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 35 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product, Self-monitoring Blood Glucose Systems 2017–2027

Table 36 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product, Continuous Glucose Monitoring Systems 2017–2027

Table 37 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2018-2028

Table 38 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2018-2028

Table 39 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027

List of Figures

Figure 01 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, 2017–2027

Figure 03 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Product Type, 2019 and 2027

Figure 04 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Product Type, 2018–2027 

Figure 05 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Self-monitoring Blood Glucose Systems, 2017–2027

Figure 06 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Continuous Glucose Monitoring Systems, 2017–2027

Figure 07 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Application, 2019 and 2027

Figure 08 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Application, 2019–2027 

Figure 09 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), Type 1 Diabetes, 2017–2027

Figure 10 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Type 2 Diabetes, 2017–2027

Figure 11 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), Gestational Diabetes, 2017–2027

Figure 12 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Testing Site, 2019 and 2027

Figure 13 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Testing Site, 2019–2027

Figure 14 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fingertip Testing, 2017-2027

Figure 15 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Alternate Site Testing, 2017-2027

Figure 16 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Patient Care Setting, 2019 and 2027

Figure 17 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Patient Care Setting, 2019–2027 

Figure 18 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Self/Home Care, 2017–2027

Figure 19 Global Specialty Clinics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027

Figure 20 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinics, 2017–2027

Figure 21 Global Blood Glucose Monitoring Systems Market Attractiveness, by Region, 2019–2027 

Figure 22 Global Blood Glucose Monitoring Systems Market Value Share, by Region, 2019 and 2027

Figure 23 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 24 Americas Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 25 Americas Blood Glucose Monitoring System Market Value Share, by Country, 2018 and 2027

Figure 26 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 27 Blood Glucose Monitoring System Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 28 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027

Figure 29 Americas Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027

Figure 30 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027

Figure 31 Americas Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027

Figure 32 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027

Figure 33 Americas Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027

Figure 34 Americas Self-monitoring Blood Glucose Systems Market Share, by Company, 2018

Figure 35 Americas Self-monitoring Blood Glucose Systems Market Share, by Mid-sized Company, 2018

Figure 36 Americas Continuous Glucose Monitoring Systems Market Share, by Company, 2018

Figure 37 Americas Continuous Glucose Monitoring Systems Market Share, by Mid-sized Company, 2018

Figure 38 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 39 Europe Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-Region, 2019–2027

Figure 40 Europe Blood Glucose Monitoring System Market Value Share, by Country/Sub-Region, 2018 and 2027

Figure 41 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Product, 2018 and 2027

Figure 42 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Product, 2019–2027

Figure 43 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027

Figure 44 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027

Figure 45 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027

Figure 46 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027

Figure 47 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027

Figure 48 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027

Figure 49 Europe & Middle East Africa Self-monitoring Blood Glucose Systems Market Share, by Company, 2018

Figure 50 Europe & Middle East Africa Self-monitoring Blood Glucose Systems Market Share, by Mid-sized Company, 2018

Figure 51 Europe & Middle East Africa Continuous Glucose Monitoring Systems Market Share, by Company, 2018

Figure 52 Europe & Middle East Africa Continuous Glucose Monitoring Systems Market Share, by Mid-sized Company, 2018

Figure 53 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 54 Asia Pacific Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-Region, 2019–2027

Figure 55 Asia Pacific Blood Glucose Monitoring System Market Value Share, by Country/Sub-Region, 2019–2027

Figure 56 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Product, 2018 and 2027

Figure 57 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Product, 2019–2027

Figure 58 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027

Figure 59 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027

Figure 60 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027

Figure 61 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027

Figure 62 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027

Figure 63 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027

Figure 64 Asia Pacific Self-monitoring Blood Glucose Systems Market Share, by Company, 2018

Figure 65 Asia Pacific Self-monitoring Blood Glucose Systems Market Share, by Mid-sized Company, 2018

Figure 66 Asia Pacific Continuous Glucose Monitoring Systems Market Share, by Company, 2018

Figure 67 Asia Pacific Continuous Glucose Monitoring Systems Market Share, by Mid-sized Company, 2018

Figure 68 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),

Figure 69 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70 Middle East & Africa Blood Glucose Monitoring System Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 71 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Product, 2018 and 2027

Figure 72 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Product, 2019–2027

Figure 73 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027

Figure 74 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027

Figure 75 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027

Figure 76 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027

Figure 77 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027

Figure 78 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027

Figure 79 Global Self-monitoring Blood Glucose Systems Market Share, by Company, 2018

Figure 80 Global Continuous Glucose Monitoring Systems Market Share, by Company, 2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Blood Glucose Monitoring Systems Market